<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">34189496</PMID>
      <DateRevised>
        <Year>2021</Year>
        <Month>07</Month>
        <Day>16</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2667-2421</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>11</Volume>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>IBRO neuroscience reports</Title>
          <ISOAbbreviation>IBRO Neurosci Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Reversal of motor-skill transfer impairment by trihexyphenidyl and reduction of dorsolateral striatal cholinergic interneurons in <i>Dyt1</i> ΔGAG knock-in mice.</ArticleTitle>
        <Pagination>
          <StartPage>1</StartPage>
          <EndPage>7</EndPage>
          <MedlinePgn>1-7</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ibneur.2021.05.003</ELocationID>
        <Abstract>
          <AbstractText>DYT-TOR1A or DYT1 early-onset generalized dystonia is an inherited movement disorder characterized by sustained muscle contractions causing twisting, repetitive movements, or abnormal postures. The majority of the DYT1 dystonia patients have a trinucleotide GAG deletion in <i>DYT1/TOR1A</i>. Trihexyphenidyl (THP), an antagonist for excitatory muscarinic acetylcholine receptor M1, is commonly used to treat dystonia. <i>Dyt1</i> heterozygous ΔGAG knock-in (KI) mice, which have the corresponding mutation, exhibit impaired motor-skill transfer. Here, the effect of THP injection during the treadmill training period on the motor-skill transfer to the accelerated rotarod performance was examined. THP treatment reversed the motor-skill transfer impairment in <i>Dyt1</i> KI mice. Immunohistochemistry showed that <i>Dyt1</i> KI mice had a significant reduction of the dorsolateral striatal cholinergic interneurons. In contrast, Western blot analysis showed no significant alteration in the expression levels of the striatal enzymes and transporters involved in the acetylcholine metabolism. The results suggest a functional alteration of the cholinergic system underlying the impairment of motor-skill transfer and the pathogenesis of DYT1 dystonia. Training with THP in a motor task may improve another motor skill performance in DYT1 dystonia.</AbstractText>
          <CopyrightInformation>© 2021 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yokoi</LastName>
            <ForeName>Fumiaki</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Norman Fixel Institute of Neurological Diseases, McKnight Brain Institute, and Department of Neurology, College of Medicine, University of Florida, Gainesville, FL 32610-0236, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dang</LastName>
            <ForeName>Mai Tu</ForeName>
            <Initials>MT</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Lin</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Norman Fixel Institute of Neurological Diseases, McKnight Brain Institute, and Department of Neurology, College of Medicine, University of Florida, Gainesville, FL 32610-0236, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Sciences, Center for Brain Repair, Florida State University College of Medicine, Tallahassee, FL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dexter</LastName>
            <ForeName>Kelly M</ForeName>
            <Initials>KM</Initials>
            <AffiliationInfo>
              <Affiliation>Norman Fixel Institute of Neurological Diseases, McKnight Brain Institute, and Department of Neurology, College of Medicine, University of Florida, Gainesville, FL 32610-0236, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Efimenko</LastName>
            <ForeName>Iakov</ForeName>
            <Initials>I</Initials>
            <AffiliationInfo>
              <Affiliation>Norman Fixel Institute of Neurological Diseases, McKnight Brain Institute, and Department of Neurology, College of Medicine, University of Florida, Gainesville, FL 32610-0236, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Krishnaswamy</LastName>
            <ForeName>Shiv</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Norman Fixel Institute of Neurological Diseases, McKnight Brain Institute, and Department of Neurology, College of Medicine, University of Florida, Gainesville, FL 32610-0236, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Villanueva</LastName>
            <ForeName>Matthew</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Norman Fixel Institute of Neurological Diseases, McKnight Brain Institute, and Department of Neurology, College of Medicine, University of Florida, Gainesville, FL 32610-0236, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Misztal</LastName>
            <ForeName>Carly I</ForeName>
            <Initials>CI</Initials>
            <AffiliationInfo>
              <Affiliation>Norman Fixel Institute of Neurological Diseases, McKnight Brain Institute, and Department of Neurology, College of Medicine, University of Florida, Gainesville, FL 32610-0236, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gerard</LastName>
            <ForeName>Malinda</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Norman Fixel Institute of Neurological Diseases, McKnight Brain Institute, and Department of Neurology, College of Medicine, University of Florida, Gainesville, FL 32610-0236, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lynch</LastName>
            <ForeName>Patrick</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Norman Fixel Institute of Neurological Diseases, McKnight Brain Institute, and Department of Neurology, College of Medicine, University of Florida, Gainesville, FL 32610-0236, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Yuqing</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Norman Fixel Institute of Neurological Diseases, McKnight Brain Institute, and Department of Neurology, College of Medicine, University of Florida, Gainesville, FL 32610-0236, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R21 NS111498</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R21 NS118397</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS075012</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS082244</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R21 NS072872</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS054246</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>06</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>IBRO Neurosci Rep</MedlineTA>
        <NlmUniqueID>101775148</NlmUniqueID>
        <ISSNLinking>2667-2421</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ACh, acetylcholine</Keyword>
        <Keyword MajorTopicYN="N">AChE, acetylcholinesterase</Keyword>
        <Keyword MajorTopicYN="N">BSA, bovine serum albumin</Keyword>
        <Keyword MajorTopicYN="N">CI, confidence interval</Keyword>
        <Keyword MajorTopicYN="N">ChAT, choline acetyltransferase</Keyword>
        <Keyword MajorTopicYN="N">ChI, cholinergic interneuron</Keyword>
        <Keyword MajorTopicYN="N">ChT, choline transporter</Keyword>
        <Keyword MajorTopicYN="N">Cholinergic interneuron</Keyword>
        <Keyword MajorTopicYN="N">DAB, 3,3′-diaminobenzidine</Keyword>
        <Keyword MajorTopicYN="N">DF, degrees of freedom</Keyword>
        <Keyword MajorTopicYN="N">Dystonia</Keyword>
        <Keyword MajorTopicYN="N">Dyt1 KI mice, Dyt1 ΔGAG heterozygous knock-in mice</Keyword>
        <Keyword MajorTopicYN="N">GAPDH, Glyceraldehyde-3-phosphate dehydrogenase</Keyword>
        <Keyword MajorTopicYN="N">KO, knockout</Keyword>
        <Keyword MajorTopicYN="N">LTD, long-term depression</Keyword>
        <Keyword MajorTopicYN="N">Motor learning</Keyword>
        <Keyword MajorTopicYN="N">PB, phosphate buffer</Keyword>
        <Keyword MajorTopicYN="N">PBS, phosphate-buffered saline</Keyword>
        <Keyword MajorTopicYN="N">PET, positron emission tomography</Keyword>
        <Keyword MajorTopicYN="N">Rotarod</Keyword>
        <Keyword MajorTopicYN="N">THP, trihexyphenidyl</Keyword>
        <Keyword MajorTopicYN="N">TOR1A</Keyword>
        <Keyword MajorTopicYN="N">TorsinA</Keyword>
        <Keyword MajorTopicYN="N">TrkA, tropomyosin receptor kinase A</Keyword>
        <Keyword MajorTopicYN="N">VAChT, vesicular acetylcholine transporter</Keyword>
        <Keyword MajorTopicYN="N">WT, wild-type</Keyword>
        <Keyword MajorTopicYN="N">n.s., not significant</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no competing financial interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>1</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>48</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34189496</ArticleId>
        <ArticleId IdType="pmc">PMC8215213</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ibneur.2021.05.003</ArticleId>
        <ArticleId IdType="pii">S2667-2421(21)00023-3</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Albanese A., Bhatia K., Bressman S.B., Delong M.R., Fahn S., Fung V.S., Hallett M., Jankovic J., Jinnah H.A., Klein C., Lang A.E., Mink J.W., Teller J.K. Phenomenology and classification of dystonia: a consensus update. Mov. Disord. 2013;28:863–873.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3729880</ArticleId>
            <ArticleId IdType="pubmed">23649720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brashers-Krug T., Shadmehr R., Bizzi E. Consolidation in human motor memory. Nature. 1996;382:252–255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8717039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breakefield X.O., Blood A.J., Li Y., Hallett M., Hanson P.I., Standaert D.G. The pathophysiological basis of dystonias. Nat. Rev. Neurosci. 2008;9:222–234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18285800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao S., Hewett J.W., Yokoi F., Lu J., Buckley A.C., Burdette A.J., Chen P., Nery F.C., Li Y., Breakefield X.O., Caldwell G.A., Caldwell K.A. Chemical enhancement of torsinA function in cell and animal models of torsion dystonia. Dis. Models Mech. 2010;3:386–396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2860854</ArticleId>
            <ArticleId IdType="pubmed">20223934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carbon M., Argyelan M., Ghilardi M.F., Mattis P., Dhawan V., Bressman S., Eidelberg D. Impaired sequence learning in dystonia mutation carriers: a genotypic effect. Brain. 2011;134:1416–1427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3097890</ArticleId>
            <ArticleId IdType="pubmed">21515903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dang M.T., Yokoi F., Cheetham C.C., Lu J., Vo V., Lovinger D.M., Li Y. An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 DeltaGAG knock-in mice. Behav. Brain Res. 2012;226:465–472.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3225290</ArticleId>
            <ArticleId IdType="pubmed">21995941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dang M.T., Yokoi F., McNaught K.S., Jengelley T.A., Jackson T., Li J., Li Y. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia. Exp. Neurol. 2005;196:452–463.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16242683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dang M.T., Yokoi F., Pence M.A., Li Y. Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci. Res. 2006;56:470–474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1794321</ArticleId>
            <ArticleId IdType="pubmed">17046090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeAndrade M.P., Trongnetrpunya A., Yokoi F., Cheetham C.C., Peng N., Wyss J.M., Ding M., Li Y. Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia. Mov. Disord. 2016;31:1633–1639.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5115930</ArticleId>
            <ArticleId IdType="pubmed">27241685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DeAndrade M.P., Yokoi F., van Groen T., Lingrel J.B., Li Y. Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism. Behav. Brain Res. 2011;216:659–665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2981691</ArticleId>
            <ArticleId IdType="pubmed">20850480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delmas P., Brown D.A. Pathways modulating neural KCNQ/M (Kv7) potassium channels. Nat. Rev. Neurosci. 2005;6:850–862.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16261179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Downs A.M., Fan X., Donsante C., Jinnah H.A., Hess E.J. Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia. Neurobiol. Dis. 2019;125:115–122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6863078</ArticleId>
            <ArticleId IdType="pubmed">30707939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eskow Jaunarajs K.L., Bonsi P., Chesselet M.F., Standaert D.G., Pisani A. Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia. Prog. Neurobiol. 2015;127–128:91–107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4420693</ArticleId>
            <ArticleId IdType="pubmed">25697043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fahn S. High dosage anticholinergic therapy in dystonia. Neurology. 1983;33:1255–1261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6136938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franklin K.B.J., Paxinos G.  The Mouse Brain in stereotaxic coordinates. Third ed. Elsevier Inc; San Diego: 2008. </Citation>
        </Reference>
        <Reference>
          <Citation>Ghilardi M.F., Carbon M., Silvestri G., Dhawan V., Tagliati M., Bressman S., Ghez C., Eidelberg D. Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann. Neurol. 2003;54:102–109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12838525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goodchild R.E., Kim C.E., Dauer W.T. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron. 2005;48:923–932.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16364897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imbriani P., Ponterio G., Tassone A., Sciamanna G., El Atiallah I., Bonsi P., Pisani A. Models of dystonia: an update. J. Neurosci. Methods. 2020;339</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32289333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Isaksen T.J., Kros L., Vedovato N., Holm T.H., Vitenzon A., Gadsby D.C., Khodakhah K., Lykke-Hartmann K. Hypothermia-induced dystonia and abnormal cerebellar activity in a mouse model with a single disease-mutation in the sodium-potassium pump. PLoS Genet. 2017;13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5436892</ArticleId>
            <ArticleId IdType="pubmed">28472154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jankovic J. Treatment of dystonia. Lancet Neurol. 2006;5:864–872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16987733</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krakauer J.W., Ghez C., Ghilardi M.F. Adaptation to visuomotor transformations: consolidation, interference, and forgetting. J. Neurosci. 2005;25:473–478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6725486</ArticleId>
            <ArticleId IdType="pubmed">15647491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J., Liu Y., Li Q., Huang X., Zhou D., Xu H., Zhao F., Mi X., Wang R., Jia F. Mutation in ε-Sarcoglycan induces a Myoclonus-Dystonia syndrome-like movement disorder in mice. Neurosci. Bull. 2021;37:311–322.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7954997</ArticleId>
            <ArticleId IdType="pubmed">33355901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang C.C., Tanabe L.M., Jou S., Chi F., Dauer W.T. TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration. J. Clin. Investig. 2014;124:3080–3092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4071385</ArticleId>
            <ArticleId IdType="pubmed">24937429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim S.A., Kang U.J., McGehee D.S. Striatal cholinergic interneuron regulation and circuit effects. Front. Synaptic Neurosci. 2014;6:22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4204445</ArticleId>
            <ArticleId IdType="pubmed">25374536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y., Xing H., Yokoi F., Vaillancourt D.E., Li Y. Investigating the role of striatal dopamine receptor 2 in motor coordination and balance: insights into the pathogenesis of DYT1 dystonia. Behav. Brain Res. 2021;403</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8165729</ArticleId>
            <ArticleId IdType="pubmed">33476687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luft A.R., Buitrago M.M. Stages of motor skill learning. Mol. Neurobiol. 2005;32:205–216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16385137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazere J., Dilharreguy B., Catheline G., Vidailhet M., Deffains M., Vimont D., Ribot B., Barse E., Cif L., Mazoyer B., Langbour N., Pisani A., Allard M., Lamare F., Guehl D., Fernandez P., Burbaud P. Striatal and cerebellar vesicular acetylcholine transporter expression is disrupted in human DYT1 dystonia. Brain. 2021;144:909–923.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33638639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCool M.F., Patel S., Talati R., Ragozzino M.E. Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching. Neurobiol. Learn. Mem. 2008;89:114–124.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2293307</ArticleId>
            <ArticleId IdType="pubmed">17709264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oleas J., Yokoi F., DeAndrade M.P., Li Y.  Rodent models of autosomal dominant primary dystonia. In: LeDoux M.S., editor. Movement Disorders: Genetics and Models. Second ed. Academic Press Elsevier; New York: 2015. pp. 483–505.</Citation>
        </Reference>
        <Reference>
          <Citation>Oleas J., Yokoi F., DeAndrade M.P., Pisani A., Li Y. Engineering animal models of dystonia. Mov. Disord. 2013;28:990–1000.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3800691</ArticleId>
            <ArticleId IdType="pubmed">23893455</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozelius L.J., Hewett J.W., Page C.E., Bressman S.B., Kramer P.L., Shalish C., de Leon D., Brin M.F., Raymond D., Corey D.P., Fahn S., Risch N.J., Buckler A.J., Gusella J.F., Breakefield X.O. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 1997;17:40–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9288096</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pappas S.S., Darr K., Holley S.M., Cepeda C., Mabrouk O.S., Wong J.M., LeWitt T.M., Paudel R., Houlden H., Kennedy R.T., Levine M.S., Dauer W.T. Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons. eLife. 2015;4:08352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4473728</ArticleId>
            <ArticleId IdType="pubmed">26052670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pappas S.S., Li J., LeWitt T.M., Kim J.K., Monani U.R., Dauer W.T. A cell autonomous torsinA requirement for cholinergic neuron survival and motor control. eLife. 2018;7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6115190</ArticleId>
            <ArticleId IdType="pubmed">30117805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pisani A., Bernardi G., Ding J., Surmeier D.J. Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci. 2007;30:545–553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17904652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prado V.F., Roy A., Kolisnyk B., Gros R., Prado M.A. Regulation of cholinergic activity by the vesicular acetylcholine transporter. Biochem. J. 2013;450:265–274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23410039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richter F., Richter A. Genetic animal models of dystonia: common features and diversities. Prog. Neurobiol. 2014;121:91–113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25034123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scarduzio M., Zimmerman C.N., Jaunarajs K.L., Wang Q., Standaert D.G., McMahon L.L. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia. Exp. Neurol. 2017;295:162–175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5561742</ArticleId>
            <ArticleId IdType="pubmed">28587876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seidler R.D. Multiple motor learning experiences enhance motor adaptability. J. Cogn. Neurosci. 2004;16:65–73.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15006037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sobreviela T., Clary D.O., Reichardt L.F., Brandabur M.M., Kordower J.H., Mufson E.J. TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J. Comp. Neurol. 1994;350:587–611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2710128</ArticleId>
            <ArticleId IdType="pubmed">7890832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song C.H., Bernhard D., Bolarinwa C., Hess E.J., Smith Y., Jinnah H.A. Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of. Neurobiol. Dis. 2013;54:362–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3628999</ArticleId>
            <ArticleId IdType="pubmed">23336980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song C.H., Bernhard D., Hess E.J., Jinnah H.A. Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia. Neurobiol. Dis. 2014;62:372–380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3877700</ArticleId>
            <ArticleId IdType="pubmed">24121114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song C.H., Fan X., Exeter C.J., Hess E.J., Jinnah H.A. Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia. Neurobiol. Dis. 2012;48:66–78.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3498628</ArticleId>
            <ArticleId IdType="pubmed">22659308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sugimoto H., Ikeda K., Kawakami K. Heterozygous mice deficient in Atp1a3 exhibit motor deficits by chronic restraint stress. Behav. Brain Res. 2014;272:100–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24983657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao J., Vemula S.R., Xue Y., Khan M.M., Carlisle F.A., Waite A.J., Blake D.J., Dragatsis I., Zhao Y., LeDoux M.S. Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome. Neurobiol. Dis. 2017;98:52–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5283163</ArticleId>
            <ArticleId IdType="pubmed">27890709</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yan Z., Flores-Hernandez J., Surmeier D.J. Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons. Neuroscience. 2001;103:1017–1024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11301208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yin H.H., Mulcare S.P., Hilario M.R., Clouse E., Holloway T., Davis M.I., Hansson A.C., Lovinger D.M., Costa R.M. Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat. Neurosci. 2009;12:333–341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2774785</ArticleId>
            <ArticleId IdType="pubmed">19198605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoi F., Chen H.X., Dang M.T., Cheetham C.C., Campbell S.L., Roper S.N., Sweatt J.D., Li Y. Behavioral and electrophysiological characterization of Dyt1 heterozygous knockout mice. PLoS One. 2015;10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4370625</ArticleId>
            <ArticleId IdType="pubmed">25799505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoi F., Dang M.T., Li J., Li Y. Myoclonus, motor deficits, alterations in emotional responses and monoamine metabolism in epsilon-sarcoglycan deficient mice. J. Biochem. 2006;140:141–146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16815860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoi F., Dang M.T., Li J., Standaert D.G., Li Y. Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice. PLoS One. 2011;6:24539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3171455</ArticleId>
            <ArticleId IdType="pubmed">21931745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoi F., Dang M.T., Li Y. Improved motor performance in Dyt1 DeltaGAG heterozygous knock-in mice by cerebellar Purkinje-cell specific Dyt1 conditional knocking-out. Behav. Brain Res. 2012;230:389–398.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3322286</ArticleId>
            <ArticleId IdType="pubmed">22391119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoi F., Dang M.T., Liu J., Gandre J.R., Kwon K., Yuen R., Li Y. Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 DeltaGAG heterozygous knock-in mice. Behav. Brain Res. 2015;279:202–210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4286880</ArticleId>
            <ArticleId IdType="pubmed">25451552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoi F., Dang M.T., Miller C.A., Marshall A.G., Campbell S.L., Sweatt J.D., Li Y. Increased c-fos expression in the central nucleus of the amygdala and enhancement of cued fear memory in Dyt1 DeltaGAG knock-in mice. Neurosci. Res. 2009;65:228–235.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2757526</ArticleId>
            <ArticleId IdType="pubmed">19619587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoi F., Dang M.T., Mitsui S., Li J., Li Y. Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout mice. J. Biochem. 2008;143:39–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17956903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoi F., Jiang F., Dexter K., Salvato B., Li Y. Improved survival and overt “dystonic” symptoms in a torsinA hypofunction mouse model. Behav. Brain Res. 2020;381</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7140139</ArticleId>
            <ArticleId IdType="pubmed">31891745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoi F., Oleas J., Xing H., Liu Y., Dexter K.M., Misztal C., Gerard M., Efimenko I., Lynch P., Villanueva M., Alsina R., Krishnaswamy S., Vaillancourt D.E., Li Y. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice. Neurobiol. Dis. 2020;134</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7323754</ArticleId>
            <ArticleId IdType="pubmed">31618684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yokoi F., Yang G., Li J., DeAndrade M.P., Zhou T., Li Y. Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce. J. Biochem. 2010;148:459–466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2981491</ArticleId>
            <ArticleId IdType="pubmed">20627944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zanone P.G., Kelso J.A. Coordination dynamics of learning and transfer: collective and component levels. J. Exp. Psychol. Hum. Percept. Perform. 1997;23:1454–1480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9336961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang L., Yokoi F., Jin Y.H., Deandrade M.P., Hashimoto K., Standaert D.G., Li Y. Altered dendritic morphology of purkinje cells in Dyt1 DeltaGAG knock-in and Purkinje cell-specific Dyt1 conditional knockout mice. PLoS One. 2011;6:18357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3066238</ArticleId>
            <ArticleId IdType="pubmed">21479250</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
